S-Biomedic Company

S-Biomedic brings novel therapeutic solutions to the skin microbiome.The skin microbiome - a habitat of billions of beneficial and harmful bacteria - contributes to healthy skin. An imbalance of these bacteria can lead to a variety of skin conditions including acne, eczema, rosacea and ageing. S-Biomedic uses a targeted modulation-based technology to modify the skin microbiome. This technology can be applied in both the dermatology and cosmetic industries. They design their products using the latest advances in microbiology and dermatology. Using their technology, beneficial bacteria are selected and combined to generate products that accelerate the rebalancing of a disease microbiome. In this way, they are able to restore a healthy state back to your skin.


Connections from

Founded Date: 01.01.2014
Last Funding Type: Series A
Headquarters: Belgium, United States
Investors Number: 4
Technology: Skin Microbiome
Employee Number: 01-10
Industry: Biotechnology
Estimated Revenue: Less than $1M
Last Funding Date: 18.07.2018
Funding Status: Early Stage Venture
Total Funding: 4 658 210